These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6216863)

  • 41. Decreased monocyte interleukin-1 beta production in atopic eczema.
    Jakob T; Neuber K; Ring J
    Br J Dermatol; 1995 Mar; 132(3):384-90. PubMed ID: 7718454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contrasting effects of prostaglandin E2 and indomethacin in modulating Con A-induced human lymphocyte proliferation and suppressor cell development.
    Skoldstam L; Zoschke D; Messner R
    Clin Immunol Immunopathol; 1982 Oct; 25(1):32-42. PubMed ID: 6217939
    [No Abstract]   [Full Text] [Related]  

  • 43. Depression, immunocompetence, and prostaglandins of the E series.
    Calabrese JR; Skwerer RG; Barna B; Gulledge AD; Valenzuela R; Butkus A; Subichin S; Krupp NE
    Psychiatry Res; 1986 Jan; 17(1):41-7. PubMed ID: 2935897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prostaglandin E2 of the upper aerodigestive tract.
    Johnson JT; Rabin BS; Wagner RL
    Ann Otol Rhinol Laryngol; 1987; 96(2 Pt 1):213-6. PubMed ID: 3471170
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immune-complex induced prostaglandin production by monocytes of normal human subjects and cancer patients.
    Poleshuck LC; Strausser HR
    Prostaglandins Med; 1980 May; 4(5):363-75. PubMed ID: 7403334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decreased interleukin 1 activity in culture supernatant of lipopolysaccharide stimulated monocytes from patients with liver cirrhosis and hepatocellular carcinoma.
    Yokota M; Sakamoto S; Koga S; Ibayashi H
    Clin Exp Immunol; 1987 Feb; 67(2):335-42. PubMed ID: 3038436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanism of suppression of the depressed lymphocyte response in lung cancer patients.
    Alberola V; González-Molina A; Trenor A; San Martín B; Lluch A; Palau F; Marín J; García-Conde FJ
    Allergol Immunopathol (Madr); 1985; 13(3):213-9. PubMed ID: 2931010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Staphylococcal exopolysaccharides inhibit lymphocyte proliferative responses by activation of monocyte prostaglandin production.
    Stout RD; Ferguson KP; Li YN; Lambe DW
    Infect Immun; 1992 Mar; 60(3):922-7. PubMed ID: 1541565
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of anti-tuberculosis drugs on the production of prostaglandin E2 and on mononuclear leucocyte transformation.
    Zeis BM
    Chemotherapy; 1987; 33(3):204-10. PubMed ID: 3474108
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endogenous prostaglandin E2 enhances polyclonal immunoglobulin production by tonically inhibiting T suppressor cell activity.
    Ceuppens JL; Goodwin JS
    Cell Immunol; 1982 Jun; 70(1):41-54. PubMed ID: 6214316
    [No Abstract]   [Full Text] [Related]  

  • 51. Prostaglandin sensitivity of the PHA-response of blood lymphocytes following radiation therapy for breast cancer.
    Blomgren H; Hammarström S; Wasserman J; Petrini B
    Radiother Oncol; 1986 Oct; 7(2):141-5. PubMed ID: 3466235
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis.
    Wolf GT; Hudson JL; Peterson KA; Miller HL; McClatchey KD
    Otolaryngol Head Neck Surg; 1986 Sep; 95(2):142-52. PubMed ID: 2954014
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor infiltrating lymphocytes in squamous cell carcinoma of the head and neck: mechanisms of enhancement using prostaglandin synthetase inhibitors.
    Cross DS; Platt JL; Juhn SK; Bach FH; Adams GL
    Adv Exp Med Biol; 1997; 400B():1013-24. PubMed ID: 9547657
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A prospective study of squamous head and neck carcinoma. Immunologic aberrations in patients who develop recurrent disease.
    Huang AT; Mold NG; Fisher SR; Brantley BA; Cole TB; Wallman MJ; Crocker IR
    Cancer; 1987 May; 59(10):1721-6. PubMed ID: 2950991
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies on lymphocyte hyporesponsiveness in cirrhosis: the role of increased monocyte suppressor cell activity.
    Holdstock G; Chastenay BF; Krawitt EL
    Gastroenterology; 1982 Feb; 82(2):206-12. PubMed ID: 6459260
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of nonsteroidal antiinflammatory drugs on immune function.
    Goodwin JS; Ceuppens JL
    Semin Arthritis Rheum; 1983 Aug; 13(1 Suppl 1):134-43. PubMed ID: 6226096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blockade of adenosine A2A receptor enhances CD8
    Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
    Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of IL-10 and IL-10 receptors on peripheral blood lymphocytes and monocytes in human head and neck squamous cell carcinoma.
    Kato H; Whiteside TL
    Tokai J Exp Clin Med; 2011 Dec; 36(4):144-51. PubMed ID: 22167499
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kinetics of prostaglandin E2 and thromboxane A2 synthesis and suppression of PHA-stimulated peripheral blood mononuclear leucocytes.
    Awara W; Hillier K; Jones D
    Immunology; 1986 Dec; 59(4):557-62. PubMed ID: 3468061
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulation of thymocyte proliferative response by macrophage-derived prostaglandin E2 and interleukin 1.
    Hayari Y; Kukulansky T; Globerson A
    Eur J Immunol; 1985 Jan; 15(1):43-7. PubMed ID: 2981690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.